Palvella Therapeutics, Inc. (PVLA) stock analysis

PVLA · Palvella Therapeutics, Inc.

Latest recorded price: USD 144.60

Sector and industry: Healthcare · Biotechnology

Fiscal 2023 figures: revenue growth 13.4%, free cash flow margin -126.1%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare